-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ssj6H3POOCtjmPi+3tIXXVYWrJ2dh+qAjTAUKO12LSVuno6JfrE06OUikCd55/zH 49vy5WN99z9C/pJrovRWCw== 0001209191-10-028402.txt : 20100517 0001209191-10-028402.hdr.sgml : 20100517 20100517213915 ACCESSION NUMBER: 0001209191-10-028402 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100513 FILED AS OF DATE: 20100517 DATE AS OF CHANGE: 20100517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seiwert Scott CENTRAL INDEX KEY: 0001458451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29801 FILM NUMBER: 10840954 MAIL ADDRESS: STREET 1: C/O INTERMUNE,INC. STREET 2: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERMUNE INC CENTRAL INDEX KEY: 0001087432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943296648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3280 BAYSHORE STREET 2: BLVD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415 466 2200 MAIL ADDRESS: STREET 1: 3280 BAYSHORE BLVD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: INTERMUNE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000121 4 1 c01341_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2010-05-13 0001087432 INTERMUNE INC ITMN 0001458451 Seiwert Scott 3280 BAYSHORE BLVD. BRISBANE CA 94005 0 1 0 0 SVP, Rsearch/ Preclinical Dev. Common Stock 2010-05-14 4 S 0 625 10.71 D 34893 D The reporting person sold the noted securities in connection with the vesting of 625 shares on 5/13/10 (which represents a portion of the previously reported equity incentive grant made on 5/13/2008). By: /s/Robin J. Steele, Attorney-in-fact for: Scott Seiwert 2010-05-17 -----END PRIVACY-ENHANCED MESSAGE-----